Biomechanics in health and disease:
advanced physical tools for innovative early diagnosis
H2020-MSCA-ITN-2018 n. 812772

INT

Fondazione IRCCS Instituto Nazionale dei Tumori di Milano

INT     

 

Structure involved

Genetic Epidemiology and Pharmacogenomics Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano (INT) 

 

Principal Investigator

Dr. Manuela Gariboldi 

Manuela Gariboldi is a researcher at the Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano. She obtained a MsC in Biology and the PhD in Medical Genetics at the University of Milano. Dr. Gariboldi is an expert in the functional classification of cancer using coding and non-coding transcripts and has contributed to a better understanding of the human transcriptome. Her interests have recently extended to the development of 3D-models from CRC and normal tissues, also including the tumor microenvironment, to use for identify new targets and develop new therapeutic approaches.

ORCID: orcid.org/0000-0001-8406-165X

Website: www.istitutotumori.mi.it